Restylane Defyne in a Stepwise Treatment Approach

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
Lower Face Folds and Lines
Interventions
DEVICE

Restylane Defyne

Up to 2 milliliters (ml) of Restylane Defyne per treatment site (chin and surrounding area) with maximum of total 4 ml at baseline, up to 2 ml of Restylane Defyne per NLF and ML at week 3 and optional up to 2 ml of Restylane Defyne per facial half for NLF and ML in combination with a total of 2 ml in the chin and surrounding area at week 6.

DEVICE

Restylane Defyne

Up to 2 ml of Restylane Defyne per NLF and ML at baseline, up to 2 ml of Restylane Defyne per treatment site (chin and surrounding area) with maximum of total 4 ml at week 3 and optional touch-up of up to 2 ml per facial half for NLF and ML in combination with a total of 2 ml in the chin and surrounding area at week 6.

Trial Locations (5)

35209

Galderma Research Site, Birmingham

60611

Galderma Research Site, Chicago

Unknown

Galderma Research Site, Belo Horizonte

Galderma Research Site, São Paulo

Galderma Research Site, Palermo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY